Author

Xuehao Wang

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University

Observed institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University

ORCID: 0000-0001-5849-0098

Observed ORCID: 0000-0001-5849-0098

OpenAlex ID: A5134826341

CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma

2024 · Feifan Yao, Suiqing Zhou, et al. · Cancer Letters · 40

Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances

2026 · Chunyao Fang, Suiqing Zhou, et al. · Signal Transduction and Targeted Therapy · 18

JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1

2026 · Qing Li, Kai Yu, et al. · Gut · 5

MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis

2026 · Shipeng Dai, Ziyuan Liu, et al. · Cancer Letters

MAL2 drives hepatocellular carcinoma progression by recruiting regulatory T cells via CCL22 and inducing the immunosuppressive microenvironment

2026 · Qian Zhang, Xiaowei Sun, et al. · Acta Biochimica et Biophysica Sinica

Works count: 5

Citation count: 63

H-index: 3

I10-index: 2